Bitget App
Trade smarter
News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
No results1Bitget Daily Digest (Nov 11)｜Uniswap Proposal Activates Protocol Fee Switch & UNI Burn; Monad Announces Tokenomics, 3% Airdropped to Community; Strive Increases BTC Holdings to 7,5252Zcash may see ‘violent end’ as ZEC price rallies 1500% in just two months3Bitcoin ‘double bottom’ eyes $110K, but CME gap may postpone rally
Flash
- 21:45Benchmark analyst reiterates Buy rating and $38 price target for BitdeerJinse Finance reported that the stock price of bitcoin miner Bitdeer Technologies Group (stock code BTDR) fell by more than 30% this week, dropping from just above $23 on Monday morning to about $16 on Tuesday. The company's third-quarter earnings failed to meet investors' expectations for significant artificial intelligence infrastructure upgrades, causing the stock price to continue its month-long downward trend. Nevertheless, Benchmark analyst Mark Palmer reiterated his buy rating and a target price of $38, noting in a stock report released on Tuesday that this sell-off "appears to reflect overly high investor expectations rather than any deterioration in the company's fundamentals." Palmer stated that Bitdeer's fundamentals in self-mining, hosting, and cloud services remain solid, with revenue up 174% year-over-year to nearly $170 millions, and adjusted EBITDA turning from a loss in the same period last year to $43 millions.
- 21:20The three major U.S. stock indexes closed mixed.Jinse Finance reported that the three major U.S. stock indexes closed mixed. The Dow Jones Index rose by 1.18%, the S&P 500 Index increased by 0.21%, while the Nasdaq Composite Index fell by 0.25%. Chip stocks generally declined, with Micron Technology dropping over 4%, ARM falling over 3%, and Nvidia, AMD, and Applied Materials all down more than 2%. Major technology stocks showed mixed performance: Apple rose over 2%, Netflix increased by more than 1%, while Oracle fell over 2% and Tesla dropped more than 1%.
- 21:13YZi Labs invests in regenerative medicine company Renewal BioForesight News reported that YZi Labs has announced an investment in the regenerative medicine company Renewal Bio, marking YZi Labs' first biotechnology investment since expanding its investment scope in early 2025. Renewal Bio focuses on using its proprietary Stembroid™ platform to generate human cells and tissues with fully matched DNA from patients' own cells, aiming to address the global organ shortage crisis. Renewal Bio reprograms ordinary skin or blood cells into stem cells by simulating early human developmental environments, generating various functional cells including hematopoietic, liver, heart, and pancreatic cells. The company was co-founded in 2022 by Professor Jacob Hanna of the Weizmann Institute of Science and his two doctoral students, Vladislav Krupalnik and Ohad Gafni. This round of financing will accelerate the preclinical development of Stembroid-derived hematopoietic stem cells for the treatment of leukemia and immune diseases, and support the expansion of laboratory infrastructure.